In pancreatic cancer, the oncogene KRAS induces the expression of SOX9 at both the mRNA and protein levels, including its phosphorylated form, thereby promoting SOX9 nuclear translocation and transcriptional activity (47,48). This evidence concerns the gene SOX9 and familial pancreatic carcinoma.